What's on?

Bone marrow cancer remission thanks to measles virus

16 May 2014 - 13h05 | By INSERM PRESS OFFICE | International

Photo ©Inserm/Fournier, Jean-Guy

Article published in the “Mayo Clinic Proceedings” journal describing complete remission of a 49-year old patient (after more than 6 months) suffering from bone marrow cancer following an injection of a strong dosage of the modified measles virus. The Mayo Clinic researchers have been using this to vaccinate 10 million people.

Reach the scientific article

Read the press release

Inserm researchers are able to comment this study at the Inserm unit 892 “Centre régional de recherche en cancérologie -nantes-angers”:

Marc Grégoire, Inserm research director
Head of team “Innovative therapeutic strategies inducing immune responses: application to the treatments of mesothelioma”
marc.gregoire@inserm.fr
Cell phone available by request at the Inserm press office. presse@inserm.fr

Jean-François Fonteneau
Inserm researcher
02 28 08 02 39
 jean-francois.fonteneau@inserm.fr

Mathieu Mateo
Post-PhD student at the Mayo Clinic
Mateo.Mathieu@mayo.edu

TO CITE THIS POST :
Inserm press room Bone marrow cancer remission thanks to measles virus Link : https://presse.inserm.fr/en/bone-marrow-cancer-remission-thanks-to-measles-virus/12553/



Medias
Researcher Contact

Marc Grégoire, Inserm research director Head of team "Innovative therapeutic strategies inducing immune responses: application to the treatments of mesothelioma" marc.gregoire@inserm.fr Cell phone available by request at the Inserm press office. presse@inserm.fr Jean-François Fonteneau Inserm researcher 02 28 08 02 39  jean-francois.fonteneau@inserm.fr Mathieu Mateo Post-PhD student at the Mayo Clinic Mateo.Mathieu@mayo.edu

Press Contact

Juliette Hardy  01 44 23 60 98 presse@inserm.fr

fermer
fermer
RSS Youtube